{"transactions":[{"id":1506918,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":90765,"kind":"person","name":"Haigh Adrian","position":1,"cik":"0001717425","reported_name":"Haigh Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Restricted Shste Unit","published_at":"2024-05-21T21:05:25.000Z","date":"2024-05-16","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"On May 16, 2024, Adrina Haigh was awarded restricted share units to acquire 25,000 shares of the issuer's common shares pursuant to the issuer's 2020 Equity Incentive Plan"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-third of the shares subject to this award shall be released from restriction as of May 16, 2025 (the \"Vesting Commencement Date\"). One twenty-fourth of the shares subject to this award may be released from restriction as of the last day of each month following the Vesting Commencement Date. As of April 30, 2027 and thereafter, 100% of the total number of shares subject to this award shall be released from restriction.."}],"balance_after":435246,"derivative":{"exercise_price":0,"exercise_date":"2025-05-16","expiration_date":"2034-05-16","underlying":"Common Shares","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-24-013983","document":"form4-05212024_050508.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000141588924013983/form4-05212024_050508.xml","form_type":"4"}},{"id":1506917,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":90765,"kind":"person","name":"Haigh Adrian","position":1,"cik":"0001717425","reported_name":"Haigh Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Stock Option","published_at":"2024-05-21T21:05:25.000Z","date":"2024-05-16","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On May 16, 2024, Adrian Haigh was granted incentive stock options to purchase 50,000 shares of the issuer's common shares pursuant to the issuer's 2020 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"2. One-third of the shares subject to this option may be exercised as of May 16, 2025 (the \"Vesting Commencement Date\"). One twenty-fourth of the shares subject to this option may be exercised as of the last day of each month following the Vesting Commencement Date. As of April 30, 2027 and thereafter, 100% of the total number of shares subject to this option shall be vested."}],"balance_after":410246,"derivative":{"exercise_price":7.12,"exercise_date":"2025-05-16","expiration_date":"2034-05-16","underlying":"Common Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-24-013983","document":"form4-05212024_050508.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000141588924013983/form4-05212024_050508.xml","form_type":"4"}},{"id":1534628,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":90765,"kind":"person","name":"Haigh Adrian","position":1,"cik":"0001717425","reported_name":"Haigh Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Shares","published_at":"2024-04-26T20:15:08.000Z","date":"2024-04-18","kind":"exercise","planned":true,"acquired":true,"shares":22222,"price":2.31,"value":51332.82,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"On April 18, 2024, the reporting person filed a Form 4 that mistakenly indicated a transaction code of \"S\" in Column 3 of Table I concerning the reporting person's acquisition of 22,222 common shares on April 17, 2024, and an additional 22,222 common shares on April 18, 2024, each pursuant to an option exercise pursuant to a 10b5-1 plan dated August 17, 2023.  The correct transaction code for the reporting person's acquisition of these shares is \"M\"."}],"balance_after":44444,"source":{"system":"sec-edgar","filing":"0001415889-24-011591","document":"form4a-04262024_040401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000141588924011591/form4a-04262024_040401.xml","form_type":"4/A","original_submission_date":"2024-04-18"}},{"id":1534627,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":90765,"kind":"person","name":"Haigh Adrian","position":1,"cik":"0001717425","reported_name":"Haigh Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Shares","published_at":"2024-04-26T20:15:08.000Z","date":"2024-04-17","kind":"exercise","planned":true,"acquired":true,"shares":22222,"price":2.31,"value":51332.82,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On April 18, 2024, the reporting person filed a Form 4 that mistakenly indicated a transaction code of \"S\" in Column 3 of Table I concerning the reporting person's acquisition of 22,222 common shares on April 17, 2024, and an additional 22,222 common shares on April 18, 2024, each pursuant to an option exercise pursuant to a 10b5-1 plan dated August 17, 2023.  The correct transaction code for the reporting person's acquisition of these shares is \"M\"."}],"balance_after":22222,"source":{"system":"sec-edgar","filing":"0001415889-24-011591","document":"form4a-04262024_040401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000141588924011591/form4a-04262024_040401.xml","form_type":"4/A","original_submission_date":"2024-04-18"}},{"id":1534626,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":90765,"kind":"person","name":"Haigh Adrian","position":1,"cik":"0001717425","reported_name":"Haigh Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Shares","published_at":"2024-04-26T20:10:12.000Z","date":"2024-04-16","kind":"exercise","planned":true,"acquired":true,"shares":22222,"price":2.31,"value":51332.82,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"On April 16, 2024, the reporting person filed a Form 4 that mistakenly indicated a transaction code of \"S\" in Column 3 of Table I concerning the reporting person's acquisition of 22,222 common shares on April 15, 2024, and an additional 22,222 common shares on April 16, 2024, each pursuant to an option exercise pursuant to a 10b5-1 plan dated August 17, 2023.  The correct transaction code for the reporting person's acquisition of these shares is \"M\"."}],"balance_after":44444,"source":{"system":"sec-edgar","filing":"0001415889-24-011584","document":"form4a-04262024_040402.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000141588924011584/form4a-04262024_040402.xml","form_type":"4/A","original_submission_date":"2024-04-16"}},{"id":1534625,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":90765,"kind":"person","name":"Haigh Adrian","position":1,"cik":"0001717425","reported_name":"Haigh Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Shares","published_at":"2024-04-26T20:10:12.000Z","date":"2024-04-15","kind":"exercise","planned":true,"acquired":true,"shares":22222,"price":2.31,"value":51332.82,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On April 16, 2024, the reporting person filed a Form 4 that mistakenly indicated a transaction code of \"S\" in Column 3 of Table I concerning the reporting person's acquisition of 22,222 common shares on April 15, 2024, and an additional 22,222 common shares on April 16, 2024, each pursuant to an option exercise pursuant to a 10b5-1 plan dated August 17, 2023.  The correct transaction code for the reporting person's acquisition of these shares is \"M\"."}],"balance_after":22222,"source":{"system":"sec-edgar","filing":"0001415889-24-011584","document":"form4a-04262024_040402.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000141588924011584/form4a-04262024_040402.xml","form_type":"4/A","original_submission_date":"2024-04-16"}},{"id":1537484,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":90765,"kind":"person","name":"Haigh Adrian","position":1,"cik":"0001717425","reported_name":"Haigh Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Option","published_at":"2024-04-22T23:34:12.000Z","date":"2024-04-22","kind":"exercise","planned":true,"acquired":false,"shares":22223,"price":2.31,"value":51335.13,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"Represents option exercise pursuant to a 10b5-1 plan dated August 17, 2023."}],"balance_after":360246,"derivative":{"exercise_price":2.31,"exercise_date":"2014-04-25","expiration_date":"2024-04-25","underlying":"Common Shares","underlying_shares":22223},"source":{"system":"sec-edgar","filing":"0001415889-24-011336","document":"form4-04222024_110404.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000141588924011336/form4-04222024_110404.xml","form_type":"4"}},{"id":1537483,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":90765,"kind":"person","name":"Haigh Adrian","position":1,"cik":"0001717425","reported_name":"Haigh Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Option","published_at":"2024-04-22T23:34:12.000Z","date":"2024-04-19","kind":"exercise","planned":true,"acquired":false,"shares":22222,"price":2.31,"value":51332.82,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Represents option exercise pursuant to a 10b5-1 plan dated August 17, 2023."}],"balance_after":382469,"derivative":{"exercise_price":2.31,"exercise_date":"2014-04-25","expiration_date":"2024-04-25","underlying":"Common Shares","underlying_shares":22222},"source":{"system":"sec-edgar","filing":"0001415889-24-011336","document":"form4-04222024_110404.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000141588924011336/form4-04222024_110404.xml","form_type":"4"}},{"id":1537482,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":90765,"kind":"person","name":"Haigh Adrian","position":1,"cik":"0001717425","reported_name":"Haigh Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Shares","published_at":"2024-04-22T23:34:12.000Z","date":"2024-04-22","kind":"sale","planned":true,"acquired":false,"shares":22223,"price":9.316,"value":207029.468,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Shares disposed pursuant to a 10b5-1 plan dated August 17, 2023."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-011336","document":"form4-04222024_110404.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000141588924011336/form4-04222024_110404.xml","form_type":"4"}},{"id":1537481,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":90765,"kind":"person","name":"Haigh Adrian","position":1,"cik":"0001717425","reported_name":"Haigh Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Shares","published_at":"2024-04-22T23:34:12.000Z","date":"2024-04-22","kind":"exercise","planned":true,"acquired":true,"shares":22223,"price":2.31,"value":51335.13,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Shares acquired pursuant to an option exercise pursuant to a 10b5-1 plan dated August 17, 2023."}],"balance_after":22223,"source":{"system":"sec-edgar","filing":"0001415889-24-011336","document":"form4-04222024_110404.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000141588924011336/form4-04222024_110404.xml","form_type":"4"}},{"id":1537480,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":90765,"kind":"person","name":"Haigh Adrian","position":1,"cik":"0001717425","reported_name":"Haigh Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Shares","published_at":"2024-04-22T23:34:12.000Z","date":"2024-04-19","kind":"sale","planned":true,"acquired":false,"shares":22222,"price":9.335,"value":207442.37,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Shares disposed pursuant to a 10b5-1 plan dated August 17, 2023."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-011336","document":"form4-04222024_110404.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000141588924011336/form4-04222024_110404.xml","form_type":"4"}},{"id":1537479,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":90765,"kind":"person","name":"Haigh Adrian","position":1,"cik":"0001717425","reported_name":"Haigh Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Shares","published_at":"2024-04-22T23:34:12.000Z","date":"2024-04-19","kind":"exercise","planned":true,"acquired":true,"shares":22222,"price":2.31,"value":51332.82,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares acquired pursuant to an option exercise pursuant to a 10b5-1 plan dated August 17, 2023."}],"balance_after":22222,"source":{"system":"sec-edgar","filing":"0001415889-24-011336","document":"form4-04222024_110404.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000141588924011336/form4-04222024_110404.xml","form_type":"4"}},{"id":1539105,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":90765,"kind":"person","name":"Haigh Adrian","position":1,"cik":"0001717425","reported_name":"Haigh Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Shares","published_at":"2024-04-19T01:43:32.000Z","date":"2024-04-18","kind":"exercise","planned":true,"acquired":false,"shares":22222,"price":2.31,"value":51332.82,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"Option exercise made pursuant to a 10b5-1 plan dated August 17, 2023."}],"balance_after":426913,"derivative":{"exercise_price":2.31,"exercise_date":"2014-04-25","expiration_date":"2024-04-25","underlying":"Options","underlying_shares":22222},"source":{"system":"sec-edgar","filing":"0001415889-24-011190","document":"form4-04192024_010425.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000141588924011190/form4-04192024_010425.xml","form_type":"4"}},{"id":1539104,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":90765,"kind":"person","name":"Haigh Adrian","position":1,"cik":"0001717425","reported_name":"Haigh Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Shares","published_at":"2024-04-19T01:43:32.000Z","date":"2024-04-17","kind":"exercise","planned":true,"acquired":false,"shares":22222,"price":2.31,"value":51332.82,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Option exercise made pursuant to a 10b5-1 plan dated August 17, 2023."}],"balance_after":449135,"derivative":{"exercise_price":2.31,"exercise_date":"2014-04-25","expiration_date":"2024-04-25","underlying":"Options","underlying_shares":22222},"source":{"system":"sec-edgar","filing":"0001415889-24-011190","document":"form4-04192024_010425.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000141588924011190/form4-04192024_010425.xml","form_type":"4"}},{"id":1539103,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":90765,"kind":"person","name":"Haigh Adrian","position":1,"cik":"0001717425","reported_name":"Haigh Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Shares","published_at":"2024-04-19T01:43:32.000Z","date":"2024-04-18","kind":"sale","planned":true,"acquired":false,"shares":22222,"price":9.62,"value":213775.64,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Shares disposed pursuant to a 10b5-1 plan dated August 17, 2023."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-011190","document":"form4-04192024_010425.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000141588924011190/form4-04192024_010425.xml","form_type":"4"}},{"id":1539102,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":90765,"kind":"person","name":"Haigh Adrian","position":1,"cik":"0001717425","reported_name":"Haigh Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Shares","published_at":"2024-04-19T01:43:32.000Z","date":"2024-04-17","kind":"sale","planned":true,"acquired":false,"shares":22222,"price":9.91,"value":220220.02,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Shares disposed pursuant to a 10b5-1 plan dated August 17, 2023."}],"balance_after":22222,"source":{"system":"sec-edgar","filing":"0001415889-24-011190","document":"form4-04192024_010425.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000141588924011190/form4-04192024_010425.xml","form_type":"4"}},{"id":1539101,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":90765,"kind":"person","name":"Haigh Adrian","position":1,"cik":"0001717425","reported_name":"Haigh Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Shares","published_at":"2024-04-19T01:43:32.000Z","date":"2024-04-18","kind":"sale","planned":true,"acquired":true,"shares":22222,"price":2.31,"value":51332.82,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Shares acquired pursuant to an option exercise pursuant to a 10b5-1 plan dated August 17, 2023."}],"balance_after":44444,"source":{"system":"sec-edgar","filing":"0001415889-24-011190","document":"form4-04192024_010425.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000141588924011190/form4-04192024_010425.xml","form_type":"4"}},{"id":1539100,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":90765,"kind":"person","name":"Haigh Adrian","position":1,"cik":"0001717425","reported_name":"Haigh Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Shares","published_at":"2024-04-19T01:43:32.000Z","date":"2024-04-17","kind":"sale","planned":true,"acquired":true,"shares":22222,"price":2.31,"value":51332.82,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares acquired pursuant to an option exercise pursuant to a 10b5-1 plan dated August 17, 2023."}],"balance_after":22222,"source":{"system":"sec-edgar","filing":"0001415889-24-011190","document":"form4-04192024_010425.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000141588924011190/form4-04192024_010425.xml","form_type":"4"}},{"id":1541042,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":90765,"kind":"person","name":"Haigh Adrian","position":1,"cik":"0001717425","reported_name":"Haigh Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Shares","published_at":"2024-04-16T22:00:52.000Z","date":"2024-04-16","kind":"exercise","planned":true,"acquired":false,"shares":22222,"price":2.31,"value":51332.82,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"Option exercise made pursuant to a 10b5-1 plan dated August 17, 2023."}],"balance_after":449135,"derivative":{"exercise_price":2.31,"exercise_date":"2014-04-25","expiration_date":"2024-04-25","underlying":"Options","underlying_shares":22222},"source":{"system":"sec-edgar","filing":"0001415889-24-010901","document":"form4-04162024_100446.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000141588924010901/form4-04162024_100446.xml","form_type":"4"}},{"id":1541041,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":90765,"kind":"person","name":"Haigh Adrian","position":1,"cik":"0001717425","reported_name":"Haigh Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Shares","published_at":"2024-04-16T22:00:52.000Z","date":"2024-04-15","kind":"exercise","planned":true,"acquired":false,"shares":22222,"price":2.31,"value":51332.82,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Option exercise made pursuant to a 10b5-1 plan dated August 17, 2023."}],"balance_after":471357,"derivative":{"exercise_price":2.31,"exercise_date":"2014-04-25","expiration_date":"2024-04-25","underlying":"Options","underlying_shares":22222},"source":{"system":"sec-edgar","filing":"0001415889-24-010901","document":"form4-04162024_100446.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000141588924010901/form4-04162024_100446.xml","form_type":"4"}},{"id":1541040,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":90765,"kind":"person","name":"Haigh Adrian","position":1,"cik":"0001717425","reported_name":"Haigh Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Shares","published_at":"2024-04-16T22:00:52.000Z","date":"2024-04-16","kind":"sale","planned":true,"acquired":false,"shares":22222,"price":10.2776,"value":228388.8272,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Shares acquired pursuant to a 10b5-1 plan dated August 17, 2023."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-010901","document":"form4-04162024_100446.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000141588924010901/form4-04162024_100446.xml","form_type":"4"}},{"id":1541039,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":90765,"kind":"person","name":"Haigh Adrian","position":1,"cik":"0001717425","reported_name":"Haigh Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Shares","published_at":"2024-04-16T22:00:52.000Z","date":"2024-04-15","kind":"sale","planned":true,"acquired":false,"shares":22222,"price":10.2958,"value":228793.2676,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Shares disposed pursuant to a 10b5-1 plan dated August 17, 2023."}],"balance_after":22222,"source":{"system":"sec-edgar","filing":"0001415889-24-010901","document":"form4-04162024_100446.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000141588924010901/form4-04162024_100446.xml","form_type":"4"}},{"id":1541038,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":90765,"kind":"person","name":"Haigh Adrian","position":1,"cik":"0001717425","reported_name":"Haigh Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Shares","published_at":"2024-04-16T22:00:52.000Z","date":"2024-04-16","kind":"sale","planned":true,"acquired":true,"shares":22222,"price":2.31,"value":51332.82,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Shares acquired pursuant to an option exercise pursuant to a 10b5-1 plan dated August 17, 2023."}],"balance_after":44444,"source":{"system":"sec-edgar","filing":"0001415889-24-010901","document":"form4-04162024_100446.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000141588924010901/form4-04162024_100446.xml","form_type":"4"}},{"id":1541037,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":90765,"kind":"person","name":"Haigh Adrian","position":1,"cik":"0001717425","reported_name":"Haigh Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Shares","published_at":"2024-04-16T22:00:52.000Z","date":"2024-04-15","kind":"sale","planned":true,"acquired":true,"shares":22222,"price":2.31,"value":51332.82,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares acquired pursuant to an option exercise pursuant to a 10b5-1 plan dated August 17, 2023."}],"balance_after":22222,"source":{"system":"sec-edgar","filing":"0001415889-24-010901","document":"form4-04162024_100446.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000141588924010901/form4-04162024_100446.xml","form_type":"4"}},{"id":1813727,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":90765,"kind":"person","name":"Haigh Adrian","position":1,"cik":"0001717425","reported_name":"Haigh Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Stock Option","published_at":"2023-08-07T20:01:02.000Z","date":"2023-08-07","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On August 7, 2023, Adrian Haigh was granted a stock option to purchase 200,000 shares of the issuer's common shares pursuant to the issuers 2020 Euity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third of grant will vest upon the first anniversary date of the grant. On the last day of each successive month, one-twenty fourth of the grant shall vest such that vesting is complete as of third anniversary of grant date."}],"balance_after":493579,"derivative":{"exercise_price":8.03,"exercise_date":"2024-08-07","expiration_date":"2033-08-07","underlying":"Common Shares","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001415889-23-011895","document":"form4-08072023_080855.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000141588923011895/form4-08072023_080855.xml","form_type":"4"}},{"id":1857014,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":90765,"kind":"person","name":"Haigh Adrian","position":1,"cik":"0001717425","reported_name":"Haigh Adrian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2023-06-13T14:22:20.000Z","date":"2023-06-12","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On June 12, 2023, Adrian Haigh was granted a non-qualified stock option to purchase 20,000 shares of the issuer's common shares pursuant to the issuer's Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is 100% vested of date of grant."}],"balance_after":293.579,"derivative":{"exercise_price":8.78,"exercise_date":"2023-06-12","expiration_date":"2033-06-12","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-23-009691","document":"form4-06132023_020615.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000141588923009691/form4-06132023_020615.xml","form_type":"4"}},{"id":2229692,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":90765,"kind":"person","name":"Haigh Adrian","position":1,"cik":"0001717425","reported_name":"Haigh Adrian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-16T13:23:45.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On June 14, 2022, Adrian Haigh was granted a non-qualified stock option to purchase 20,000 shares of the Issuer's common shares pursuant to the Issuer's Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is 100% vested on the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":5.59,"expiration_date":"2032-06-14","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-22-071688","document":"tm2218610-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000110465922071688/tm2218610-3_4seq1.xml","form_type":"4"}},{"id":2649575,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":90765,"kind":"person","name":"Haigh Adrian","position":1,"cik":"0001717425","reported_name":"Haigh Adrian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-30T19:42:57.000Z","date":"2021-06-29","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On June 29, 2021, Adrian Haigh was granted a non-qualified stock option to purchase 20,000 shares of the Issuer's common shares pursuant to the Issuer's Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is 100% vested on the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":7.52,"expiration_date":"2031-06-29","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-21-087515","document":"tm2121155-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000110465921087515/tm2121155-3_4seq1.xml","form_type":"4"}},{"id":3057069,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":90765,"kind":"person","name":"Haigh Adrian","position":1,"cik":"0001717425","reported_name":"Haigh Adrian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-08-14T19:16:13.000Z","date":"2020-08-13","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On August 13, 2020, Adrian Haigh was granted a non-qualified stock option to purchase 20,000 shares of the Issuer's common shares pursuant to the Issuer's Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is 100% vested on the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":6.17,"expiration_date":"2030-08-13","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-20-095446","document":"tm2027709d3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000110465920095446/tm2027709d3_4.xml","form_type":"4"}},{"id":3483855,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":90765,"kind":"person","name":"Haigh Adrian","position":1,"cik":"0001717425","reported_name":"Haigh Adrian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-20T00:34:01.000Z","date":"2019-06-18","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On June 18, 2019, Adrian Haigh was granted an incentive stock option to purchase 20,000 shares of the Issuer's common shares pursuant to the Issuer's Amended and Restated Stock Option Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is 100% vested on the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":4.26,"expiration_date":"2029-06-18","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001144204-19-031565","document":"tv523894_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000114420419031565/tv523894_4.xml","form_type":"4"}},{"id":3898137,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":90765,"kind":"person","name":"Haigh Adrian","position":1,"cik":"0001717425","reported_name":"Haigh Adrian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-11T14:43:17.000Z","date":"2018-06-08","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On June 8, 2018, Adrian Haigh was granted an incentive stock option to purchase 20,000 common shares of the Issuer pursuant to the Issuer's Amended and Restated Stock Option Plan.  The option is 100% vested on the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":10.93,"exercise_date":"2018-06-08","expiration_date":"2025-06-08","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001144204-18-033679","document":"tv496272_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000114420418033679/tv496272_4.xml","form_type":"4"}}]}